David P. Bonita - Director, 10%+ Owner at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David P. Bonita since 11/5/2023

Holdings reported by David P. Bonita for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.2M $63.6M $15.14 Jun 2, 2022 By OrbiMed Private Investments VII, LP
Stock Options (Right to Buy) 8.5K Jun 2, 2022 Direct Common Stock

Transactions reported by David P. Bonita for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.